These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 11021997

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
    Kung SK, An DS, Chen IS.
    J Virol; 2000 Apr; 74(8):3668-81. PubMed ID: 10729143
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter.
    Vile RG, Diaz RM, Miller N, Mitchell S, Tuszyanski A, Russell SJ.
    Virology; 1995 Dec 01; 214(1):307-13. PubMed ID: 8525635
    [Abstract] [Full Text] [Related]

  • 6. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
    Zhao-Emonet JC, Marodon G, Pioche-Durieu C, Cosset FL, Klatzmann D.
    J Gene Med; 2000 Dec 01; 2(6):416-25. PubMed ID: 11199262
    [Abstract] [Full Text] [Related]

  • 7. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease.
    Costa GL, Benson JM, Seroogy CM, Achacoso P, Fathman CG, Nolan GP.
    J Immunol; 2000 Apr 01; 164(7):3581-90. PubMed ID: 10725713
    [Abstract] [Full Text] [Related]

  • 8. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position.
    Hoeben RC, Migchielsen AA, van der Jagt RC, van Ormondt H, van der Eb AJ.
    J Virol; 1991 Feb 01; 65(2):904-12. PubMed ID: 1702844
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
    Weber EL, Cannon PM.
    Hum Gene Ther; 2007 Sep 01; 18(9):849-60. PubMed ID: 17767401
    [Abstract] [Full Text] [Related]

  • 12. The U3 region of Moloney murine leukemia virus contains position-independent cis-acting sequences involved in the nuclear export of full-length viral transcripts.
    Volkova NA, Fomina EG, Smolnikova VV, Zinovieva NA, Fomin IK.
    J Biol Chem; 2014 Jul 18; 289(29):20158-69. PubMed ID: 24878957
    [Abstract] [Full Text] [Related]

  • 13. High-resolution analysis of cytosine methylation in the 5ĺong terminal repeat of retroviral vectors.
    Wang L, Robbins PB, Carbonaro DA, Kohn DB.
    Hum Gene Ther; 1998 Nov 01; 9(16):2321-30. PubMed ID: 9829531
    [Abstract] [Full Text] [Related]

  • 14. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
    Fan H, Mittal S, Chute H, Chao E, Pattengale PK.
    J Virol; 1986 Oct 01; 60(1):204-14. PubMed ID: 3747027
    [Abstract] [Full Text] [Related]

  • 15. Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
    Moiani A, Miccio A, Rizzi E, Severgnini M, Pellin D, Suerth JD, Baum C, De Bellis G, Mavilio F.
    PLoS One; 2013 Oct 01; 8(1):e55721. PubMed ID: 23383272
    [Abstract] [Full Text] [Related]

  • 16. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
    Bosticardo M, Ghosh A, Du Y, Jenkins NA, Copeland NG, Candotti F.
    Mol Ther; 2009 Nov 01; 17(11):1910-8. PubMed ID: 19638958
    [Abstract] [Full Text] [Related]

  • 17. Amelioration of retroviral vector silencing in locus control region beta-globin-transgenic mice and transduced F9 embryonic cells.
    Osborne CS, Pasceri P, Singal R, Sukonnik T, Ginder GD, Ellis J.
    J Virol; 1999 Jul 01; 73(7):5490-6. PubMed ID: 10364297
    [Abstract] [Full Text] [Related]

  • 18. Use of a retroviral vector with an internal opsin promoter to direct gene expression to retinal photoreceptor cells.
    Kido M, Rich KA, Yang G, Barrón E, Kohn DB, al-Ubaidi MR, Blanks JC.
    Curr Eye Res; 1996 Aug 01; 15(8):833-44. PubMed ID: 8921226
    [Abstract] [Full Text] [Related]

  • 19. A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers.
    Ferrari G, Salvatori G, Rossi C, Cossu G, Mavilio F.
    Hum Gene Ther; 1995 Jun 01; 6(6):733-42. PubMed ID: 7548273
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting the performance of different long terminal repeats in the retroviral vector.
    Kim S, Lee K, Kim MD, Kang S, Joo CW, Kim JM, Kim SH, Yu SS, Kim S.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1017-22. PubMed ID: 16574062
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.